

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41541419 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.41541419 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96545983 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25560246 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.21875667 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.21875667 |
| 7 | piRNA metabolic process (GO:0034587) | 4.20231635 |
| 8 | proteasome assembly (GO:0043248) | 4.13737671 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.01251165 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 3.88580398 |
| 11 | base-excision repair, AP site formation (GO:0006285) | 3.80453684 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.71995112 |
| 13 | regulation of RIG-I signaling pathway (GO:0039535) | 3.62228788 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 3.59906188 |
| 15 | response to type I interferon (GO:0034340) | 3.52481904 |
| 16 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.51992328 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50305448 |
| 18 | cellular response to type I interferon (GO:0071357) | 3.50153756 |
| 19 | type I interferon signaling pathway (GO:0060337) | 3.50153756 |
| 20 | B cell mediated immunity (GO:0019724) | 3.45809761 |
| 21 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.33469876 |
| 22 | positive regulation of humoral immune response (GO:0002922) | 3.27385416 |
| 23 | ribosome assembly (GO:0042255) | 3.24714404 |
| 24 | histone H2A monoubiquitination (GO:0035518) | 3.24347981 |
| 25 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.24280580 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24215468 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.21466652 |
| 28 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.19901536 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.17539585 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16372870 |
| 31 | regulation of response to interferon-gamma (GO:0060330) | 3.16008463 |
| 32 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.08237521 |
| 33 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.06089134 |
| 34 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.04563182 |
| 35 | proline biosynthetic process (GO:0006561) | 3.04483646 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.02932183 |
| 37 | T cell migration (GO:0072678) | 3.01823158 |
| 38 | formation of translation preinitiation complex (GO:0001731) | 3.01158785 |
| 39 | negative regulation of ligase activity (GO:0051352) | 2.99905797 |
| 40 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.99905797 |
| 41 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.99875333 |
| 42 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.99063474 |
| 43 | regulation of female gonad development (GO:2000194) | 2.98946165 |
| 44 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.96907765 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 2.95112596 |
| 46 | pentose-phosphate shunt (GO:0006098) | 2.95050752 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.92640855 |
| 48 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.92416672 |
| 49 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.92416672 |
| 50 | histone H2A ubiquitination (GO:0033522) | 2.92368800 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 2.90479685 |
| 52 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88458415 |
| 53 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88458415 |
| 54 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88458415 |
| 55 | mitotic chromosome condensation (GO:0007076) | 2.86848845 |
| 56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86515051 |
| 57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86432900 |
| 58 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.86020593 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.86020593 |
| 60 | negative thymic T cell selection (GO:0045060) | 2.85221453 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 2.84339899 |
| 62 | negative T cell selection (GO:0043383) | 2.82258331 |
| 63 | cellular response to interferon-beta (GO:0035458) | 2.81253207 |
| 64 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.78988465 |
| 65 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.78162857 |
| 66 | citrulline biosynthetic process (GO:0019240) | 2.77400669 |
| 67 | NADPH regeneration (GO:0006740) | 2.76081905 |
| 68 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.74946029 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 2.74336854 |
| 70 | response to interferon-beta (GO:0035456) | 2.73235223 |
| 71 | protein K6-linked ubiquitination (GO:0085020) | 2.70431191 |
| 72 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.68630034 |
| 73 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.68423783 |
| 74 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.66920068 |
| 75 | mitotic metaphase plate congression (GO:0007080) | 2.65030687 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64728636 |
| 77 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.63659675 |
| 78 | myeloid dendritic cell differentiation (GO:0043011) | 2.62442743 |
| 79 | pinocytosis (GO:0006907) | 2.60686946 |
| 80 | cellular response to virus (GO:0098586) | 2.59792844 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58427133 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 2.58006184 |
| 83 | positive regulation of ligase activity (GO:0051351) | 2.57737599 |
| 84 | defense response to protozoan (GO:0042832) | 2.56064119 |
| 85 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.54545862 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 2.54417785 |
| 87 | negative regulation of meiosis (GO:0045835) | 2.53810530 |
| 88 | pentose metabolic process (GO:0019321) | 2.53456805 |
| 89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53252655 |
| 90 | sequestering of actin monomers (GO:0042989) | 2.52680673 |
| 91 | regulation of B cell differentiation (GO:0045577) | 2.52120739 |
| 92 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.51880492 |
| 93 | deoxyribonucleotide catabolic process (GO:0009264) | 2.49705960 |
| 94 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.49251919 |
| 95 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.48322106 |
| 96 | ribosomal large subunit biogenesis (GO:0042273) | 2.45329125 |
| 97 | regulation of hypersensitivity (GO:0002883) | 2.44739968 |
| 98 | establishment of viral latency (GO:0019043) | 2.43218581 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.42834586 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 2.40669216 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.40629523 |
| 102 | ribosomal small subunit biogenesis (GO:0042274) | 2.38386959 |
| 103 | negative regulation of B cell apoptotic process (GO:0002903) | 2.37630249 |
| 104 | deoxyribose phosphate catabolic process (GO:0046386) | 2.37254126 |
| 105 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.36750886 |
| 106 | leukocyte aggregation (GO:0070486) | 2.36518826 |
| 107 | thymic T cell selection (GO:0045061) | 2.35829054 |
| 108 | telomere maintenance via recombination (GO:0000722) | 2.35730754 |
| 109 | nucleotide salvage (GO:0043173) | 2.35480735 |
| 110 | ribosome biogenesis (GO:0042254) | 2.34447520 |
| 111 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.34441298 |
| 112 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.34262022 |
| 113 | response to protozoan (GO:0001562) | 2.33236463 |
| 114 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.33119527 |
| 115 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32562407 |
| 116 | establishment of chromosome localization (GO:0051303) | 2.32553033 |
| 117 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.32036202 |
| 118 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.31888708 |
| 119 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.30389575 |
| 120 | regulation of ligase activity (GO:0051340) | 2.30351271 |
| 121 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.29532666 |
| 122 | mitotic nuclear envelope disassembly (GO:0007077) | 2.29357464 |
| 123 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.29043662 |
| 124 | DNA methylation involved in gamete generation (GO:0043046) | 2.28695076 |
| 125 | gene silencing by RNA (GO:0031047) | 2.28396141 |
| 126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.27453937 |
| 127 | glucose catabolic process (GO:0006007) | 2.27268184 |
| 128 | metaphase plate congression (GO:0051310) | 2.26600288 |
| 129 | DNA deamination (GO:0045006) | 2.26436979 |
| 130 | regulation of cellular amine metabolic process (GO:0033238) | 2.26328381 |
| 131 | positive regulation of T cell apoptotic process (GO:0070234) | 2.25210172 |
| 132 | nuclear envelope reassembly (GO:0031468) | 2.24331348 |
| 133 | mitotic nuclear envelope reassembly (GO:0007084) | 2.24331348 |
| 134 | negative regulation of protein ubiquitination (GO:0031397) | 2.23918525 |
| 135 | NADH metabolic process (GO:0006734) | 2.23238299 |
| 136 | interferon-gamma production (GO:0032609) | 2.22623920 |
| 137 | negative regulation of viral genome replication (GO:0045071) | 2.21809363 |
| 138 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.21746382 |
| 139 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.20885974 |
| 140 | cell cycle G1/S phase transition (GO:0044843) | 2.20885974 |
| 141 | pyrimidine nucleoside salvage (GO:0043097) | 2.20544689 |
| 142 | pyrimidine-containing compound salvage (GO:0008655) | 2.20544689 |
| 143 | DNA strand elongation (GO:0022616) | 2.20529699 |
| 144 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.20127921 |
| 145 | positive regulation of cell cycle arrest (GO:0071158) | 2.20127562 |
| 146 | response to interferon-alpha (GO:0035455) | 2.20044995 |
| 147 | establishment of integrated proviral latency (GO:0075713) | 2.19901903 |
| 148 | positive regulation of isotype switching (GO:0045830) | 2.19805458 |
| 149 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.19229800 |
| 150 | regulation of translation in response to stress (GO:0043555) | 2.18644179 |
| 151 | cellular response to interferon-gamma (GO:0071346) | 2.18105277 |
| 152 | regulation of histone H3-K27 methylation (GO:0061085) | 2.17456606 |
| 153 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.16995906 |
| 154 | natural killer cell mediated immunity (GO:0002228) | 2.16995906 |
| 155 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.16541200 |
| 156 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.16365363 |
| 157 | T cell apoptotic process (GO:0070231) | 2.16103662 |
| 158 | protein targeting to mitochondrion (GO:0006626) | 2.15853761 |
| 159 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.14878705 |
| 160 | purine nucleotide salvage (GO:0032261) | 2.14822178 |
| 161 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.14046645 |
| 162 | regulation of translational termination (GO:0006449) | 2.13783807 |
| 163 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.13720653 |
| 164 | response to peptidoglycan (GO:0032494) | 2.13551866 |
| 165 | regulation of spindle organization (GO:0090224) | 2.13464715 |
| 166 | lymphocyte mediated immunity (GO:0002449) | 2.13304531 |
| 167 | T cell selection (GO:0045058) | 2.13133179 |
| 168 | regulation of sister chromatid cohesion (GO:0007063) | 2.11697111 |
| 169 | meiotic chromosome segregation (GO:0045132) | 2.11323879 |
| 170 | negative regulation of type I interferon production (GO:0032480) | 2.10917044 |
| 171 | positive regulation of interleukin-12 production (GO:0032735) | 2.10858562 |
| 172 | regulation of antigen processing and presentation (GO:0002577) | 2.10645790 |
| 173 | regulation of defense response to virus by host (GO:0050691) | 2.10589301 |
| 174 | spliceosomal snRNP assembly (GO:0000387) | 2.10211605 |
| 175 | hepatocyte apoptotic process (GO:0097284) | 2.10205906 |
| 176 | signal transduction in response to DNA damage (GO:0042770) | 2.07844705 |
| 177 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.07233540 |
| 178 | pseudouridine synthesis (GO:0001522) | 2.06444778 |
| 179 | mitotic recombination (GO:0006312) | 2.05903636 |
| 180 | autophagic vacuole fusion (GO:0000046) | 2.05859849 |
| 181 | iron-sulfur cluster assembly (GO:0016226) | 2.05624797 |
| 182 | metallo-sulfur cluster assembly (GO:0031163) | 2.05624797 |
| 183 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.05547634 |
| 184 | nucleoside salvage (GO:0043174) | 2.05519630 |
| 185 | regulation of mitochondrial translation (GO:0070129) | 2.05249781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.45950861 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.00197106 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22874260 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.00344722 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.97767577 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.68403995 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.46018700 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.43257210 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.42040140 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38651390 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28577799 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13343076 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08109903 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05334877 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.01044683 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.96559830 |
| 17 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96462380 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.93549285 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91573213 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86486919 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.86361108 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83426841 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82376608 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.81881645 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.79215827 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.76996124 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.76810783 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.75282232 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74703573 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.71573363 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69325019 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.68714194 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66121180 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65806682 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.65106152 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63619379 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.62782126 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.60704894 |
| 39 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60269640 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59667384 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58091777 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57841510 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56717871 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56562417 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.55222371 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55025517 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54900242 |
| 48 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.54577165 |
| 49 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54335219 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.51725476 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51505226 |
| 52 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.50745216 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50228554 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49860601 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.49558650 |
| 56 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.49520741 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47861884 |
| 58 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47065067 |
| 59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46133688 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45813340 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45422519 |
| 62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45417845 |
| 63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.43780182 |
| 64 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43462397 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40736340 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39132354 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.37755865 |
| 68 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36513744 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36368329 |
| 70 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35268116 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33808307 |
| 72 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30797916 |
| 73 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27920591 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.26924195 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26787813 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26428050 |
| 77 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25972043 |
| 78 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25882772 |
| 79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25821413 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25806600 |
| 81 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24916845 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24427588 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24321347 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23314751 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23166934 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19573966 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18678007 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18507063 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18407483 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18317718 |
| 91 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18192609 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18126328 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17995032 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17126332 |
| 95 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14902496 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14682023 |
| 97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14443022 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12803017 |
| 99 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10937540 |
| 100 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.09967486 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09681114 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08805114 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08651920 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08472109 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08277049 |
| 106 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08045278 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08022123 |
| 108 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07016465 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06671319 |
| 110 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05354998 |
| 111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04804801 |
| 112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04060066 |
| 113 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03677643 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03603107 |
| 115 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03009095 |
| 116 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02140995 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00499399 |
| 118 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99968571 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99906918 |
| 120 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98920522 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97889886 |
| 122 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97113326 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96646815 |
| 124 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95366753 |
| 125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94458657 |
| 126 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93034279 |
| 127 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92876584 |
| 128 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92237871 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91629593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.97655938 |
| 2 | MP0000685_abnormal_immune_system | 3.36982143 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.20972069 |
| 4 | MP0009785_altered_susceptibility_to | 3.02326922 |
| 5 | MP0005671_abnormal_response_to | 3.02291148 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.87456138 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.60235850 |
| 8 | MP0001800_abnormal_humoral_immune | 2.39050001 |
| 9 | MP0001790_abnormal_immune_system | 2.32303902 |
| 10 | MP0005387_immune_system_phenotype | 2.32303902 |
| 11 | MP0005025_abnormal_response_to | 2.26438024 |
| 12 | MP0003436_decreased_susceptibility_to | 2.21816508 |
| 13 | MP0003646_muscle_fatigue | 2.21418440 |
| 14 | MP0002723_abnormal_immune_serum | 2.15408013 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.13449513 |
| 16 | MP0002398_abnormal_bone_marrow | 2.13441144 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.10277696 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.07528328 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.07211777 |
| 20 | MP0003077_abnormal_cell_cycle | 2.07138835 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.06143337 |
| 22 | MP0001819_abnormal_immune_cell | 2.06115483 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.96988276 |
| 24 | MP0003718_maternal_effect | 1.93723719 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.91086861 |
| 26 | MP0000716_abnormal_immune_system | 1.88781498 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 1.87464516 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.85675089 |
| 29 | MP0006082_CNS_inflammation | 1.85398926 |
| 30 | MP0009840_abnormal_foam_cell | 1.84482885 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.84415425 |
| 32 | MP0002419_abnormal_innate_immunity | 1.75854967 |
| 33 | MP0002722_abnormal_immune_system | 1.73773649 |
| 34 | MP0004510_myositis | 1.72956161 |
| 35 | MP0002405_respiratory_system_inflammati | 1.72842158 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.71356462 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.66876369 |
| 38 | MP0002429_abnormal_blood_cell | 1.65696237 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.64233247 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.64233247 |
| 41 | MP0005310_abnormal_salivary_gland | 1.63430669 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.61316211 |
| 43 | MP0001873_stomach_inflammation | 1.60293217 |
| 44 | MP0004233_abnormal_muscle_weight | 1.60157508 |
| 45 | MP0003724_increased_susceptibility_to | 1.58259545 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.56591669 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.53500885 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.50966276 |
| 49 | MP0002006_tumorigenesis | 1.50189345 |
| 50 | MP0004947_skin_inflammation | 1.49453965 |
| 51 | MP0000490_abnormal_crypts_of | 1.48635558 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.46574706 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 1.43817510 |
| 54 | MP0005451_abnormal_body_composition | 1.40624216 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.40575046 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.38254786 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.38005598 |
| 58 | MP0008469_abnormal_protein_level | 1.35290304 |
| 59 | MP0008007_abnormal_cellular_replicative | 1.29910790 |
| 60 | MP0001853_heart_inflammation | 1.29451063 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.28420901 |
| 62 | MP0008058_abnormal_DNA_repair | 1.24617643 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.24364283 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.23903737 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.23628464 |
| 66 | MP0009278_abnormal_bone_marrow | 1.23290849 |
| 67 | MP0000358_abnormal_cell_content/ | 1.18899889 |
| 68 | MP0005360_urolithiasis | 1.16123864 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.15462668 |
| 70 | MP0003303_peritoneal_inflammation | 1.15057752 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.13838122 |
| 72 | MP0001119_abnormal_female_reproductive | 1.12999123 |
| 73 | MP0001666_abnormal_nutrient_absorption | 1.12136421 |
| 74 | MP0000858_altered_metastatic_potential | 1.11653876 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.11447193 |
| 76 | MP0008260_abnormal_autophagy | 1.10540386 |
| 77 | MP0002796_impaired_skin_barrier | 1.10075275 |
| 78 | MP0002254_reproductive_system_inflammat | 1.09522828 |
| 79 | MP0005501_abnormal_skin_physiology | 1.09250027 |
| 80 | MP0001881_abnormal_mammary_gland | 1.08875713 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.08521115 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 1.06993216 |
| 83 | MP0005408_hypopigmentation | 1.06653841 |
| 84 | MP0003866_abnormal_defecation | 1.05025976 |
| 85 | MP0009764_decreased_sensitivity_to | 1.01854310 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.01073619 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99494644 |
| 88 | MP0010307_abnormal_tumor_latency | 0.95870107 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.95508955 |
| 90 | MP0003075_altered_response_to | 0.94350830 |
| 91 | MP0003186_abnormal_redox_activity | 0.93338105 |
| 92 | MP0003448_altered_tumor_morphology | 0.91360419 |
| 93 | MP0000609_abnormal_liver_physiology | 0.90960824 |
| 94 | MP0005365_abnormal_bile_salt | 0.90724628 |
| 95 | MP0005083_abnormal_biliary_tract | 0.90654627 |
| 96 | MP0000313_abnormal_cell_death | 0.90283364 |
| 97 | MP0009763_increased_sensitivity_to | 0.90097191 |
| 98 | MP0000350_abnormal_cell_proliferation | 0.89766668 |
| 99 | MP0001730_embryonic_growth_arrest | 0.89556833 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89061199 |
| 101 | MP0008057_abnormal_DNA_replication | 0.89011701 |
| 102 | MP0000343_altered_response_to | 0.88740403 |
| 103 | MP0002933_joint_inflammation | 0.87938221 |
| 104 | MP0005384_cellular_phenotype | 0.84960419 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.84470751 |
| 106 | MP0003699_abnormal_female_reproductive | 0.84309803 |
| 107 | MP0002080_prenatal_lethality | 0.84079763 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.83963153 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83243689 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.82693690 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.81975688 |
| 112 | MP0001929_abnormal_gametogenesis | 0.81922201 |
| 113 | MP0000598_abnormal_liver_morphology | 0.80682656 |
| 114 | MP0002210_abnormal_sex_determination | 0.79970934 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.77596115 |
| 116 | MP0005395_other_phenotype | 0.77182579 |
| 117 | MP0002132_abnormal_respiratory_system | 0.76549578 |
| 118 | MP0008932_abnormal_embryonic_tissue | 0.73071859 |
| 119 | MP0001764_abnormal_homeostasis | 0.72700882 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.72285411 |
| 121 | MP0003786_premature_aging | 0.71082649 |
| 122 | MP0002653_abnormal_ependyma_morphology | 0.69909233 |
| 123 | MP0000653_abnormal_sex_gland | 0.68736665 |
| 124 | MP0003315_abnormal_perineum_morphology | 0.67878728 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.67273281 |
| 126 | MP0005023_abnormal_wound_healing | 0.65556254 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.64334220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.23597553 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.17643889 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.13412955 |
| 4 | Chronic otitis media (HP:0000389) | 3.99115566 |
| 5 | Myositis (HP:0100614) | 3.98604395 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.81967820 |
| 7 | Thrombocytosis (HP:0001894) | 3.65540882 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.58739781 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.58739781 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.58739781 |
| 11 | Nasal polyposis (HP:0100582) | 3.56353051 |
| 12 | Recurrent viral infections (HP:0004429) | 3.51964604 |
| 13 | Recurrent bronchitis (HP:0002837) | 3.45206268 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.38111565 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.32584011 |
| 16 | Abnormality of the fingertips (HP:0001211) | 3.24694194 |
| 17 | Cholecystitis (HP:0001082) | 3.22475984 |
| 18 | Abnormal gallbladder physiology (HP:0012438) | 3.22475984 |
| 19 | Increased IgM level (HP:0003496) | 3.22079788 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.21401216 |
| 21 | Aplastic anemia (HP:0001915) | 3.19901300 |
| 22 | Combined immunodeficiency (HP:0005387) | 3.15237743 |
| 23 | Abnormality of T cells (HP:0002843) | 3.15074367 |
| 24 | IgM deficiency (HP:0002850) | 3.10333436 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.10041450 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03439644 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.02438935 |
| 28 | Recurrent skin infections (HP:0001581) | 3.01688951 |
| 29 | T lymphocytopenia (HP:0005403) | 3.00246706 |
| 30 | Orchitis (HP:0100796) | 2.97288001 |
| 31 | Microvesicular hepatic steatosis (HP:0001414) | 2.95886245 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 2.94968372 |
| 33 | IgG deficiency (HP:0004315) | 2.93405346 |
| 34 | Reduced antithrombin III activity (HP:0001976) | 2.87429208 |
| 35 | Severe combined immunodeficiency (HP:0004430) | 2.83996232 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.83441444 |
| 37 | Optic neuritis (HP:0100653) | 2.83441444 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.77356388 |
| 39 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.76234990 |
| 40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.76234990 |
| 41 | Ragged-red muscle fibers (HP:0003200) | 2.75303836 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.72539793 |
| 43 | Loss of speech (HP:0002371) | 2.72517237 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.71179107 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70160629 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70160629 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68131380 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.65754868 |
| 49 | Stomatitis (HP:0010280) | 2.62365456 |
| 50 | Hypokinesia (HP:0002375) | 2.61914660 |
| 51 | Increased serum ferritin (HP:0003281) | 2.58893834 |
| 52 | Pustule (HP:0200039) | 2.56149605 |
| 53 | Rough bone trabeculation (HP:0100670) | 2.55083274 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.54772799 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49521724 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.49256830 |
| 57 | Oral leukoplakia (HP:0002745) | 2.46849544 |
| 58 | Degeneration of anterior horn cells (HP:0002398) | 2.40104151 |
| 59 | Abnormality of the anterior horn cell (HP:0006802) | 2.40104151 |
| 60 | Male infertility (HP:0003251) | 2.39581796 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.39272701 |
| 62 | Joint swelling (HP:0001386) | 2.39041882 |
| 63 | Increased intramyocellular lipid droplets (HP:0012240) | 2.38911222 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.36796783 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.36618971 |
| 66 | Increased serum pyruvate (HP:0003542) | 2.36029597 |
| 67 | Leukocytosis (HP:0001974) | 2.35100719 |
| 68 | Pulmonary fibrosis (HP:0002206) | 2.34892105 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 2.33554071 |
| 70 | Abnormal glycosylation (HP:0012345) | 2.33554071 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33554071 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33554071 |
| 73 | Lymphopenia (HP:0001888) | 2.32153446 |
| 74 | Entropion (HP:0000621) | 2.31986331 |
| 75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.31258715 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.31248232 |
| 77 | Vasculitis (HP:0002633) | 2.30637437 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.30073685 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.26751068 |
| 80 | Hyperammonemia (HP:0001987) | 2.25584657 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25060714 |
| 82 | Abnormal trabecular bone morphology (HP:0100671) | 2.24970305 |
| 83 | Prolonged neonatal jaundice (HP:0006579) | 2.24779860 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.24697537 |
| 85 | Meningitis (HP:0001287) | 2.23819480 |
| 86 | Agnosia (HP:0010524) | 2.22465117 |
| 87 | Bronchitis (HP:0012387) | 2.22415481 |
| 88 | Poikiloderma (HP:0001029) | 2.21680559 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.21552148 |
| 90 | Petechiae (HP:0000967) | 2.20797642 |
| 91 | Progressive external ophthalmoplegia (HP:0000590) | 2.19903263 |
| 92 | Birth length less than 3rd percentile (HP:0003561) | 2.19793903 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 2.18779457 |
| 94 | Premature ovarian failure (HP:0008209) | 2.16645798 |
| 95 | Granulocytopenia (HP:0001913) | 2.15237805 |
| 96 | Spontaneous hematomas (HP:0007420) | 2.14400828 |
| 97 | Abnormality of eosinophils (HP:0001879) | 2.13222386 |
| 98 | Thyroiditis (HP:0100646) | 2.12901633 |
| 99 | Gastrointestinal infarctions (HP:0005244) | 2.11915899 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.11770273 |
| 101 | Pancytopenia (HP:0001876) | 2.11077054 |
| 102 | Microretrognathia (HP:0000308) | 2.10976320 |
| 103 | Cortical dysplasia (HP:0002539) | 2.10112485 |
| 104 | Encephalitis (HP:0002383) | 2.06153911 |
| 105 | Lymphoma (HP:0002665) | 2.06059914 |
| 106 | Cellulitis (HP:0100658) | 2.05095495 |
| 107 | Eosinophilia (HP:0001880) | 2.04400914 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 2.03783856 |
| 109 | Nausea (HP:0002018) | 2.02710733 |
| 110 | Amaurosis fugax (HP:0100576) | 2.01649682 |
| 111 | Agammaglobulinemia (HP:0004432) | 2.01140614 |
| 112 | Muscle fiber atrophy (HP:0100295) | 2.00811402 |
| 113 | Hepatocellular necrosis (HP:0001404) | 2.00111118 |
| 114 | Arterial thrombosis (HP:0004420) | 1.98931453 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98302197 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98302197 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98302197 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.98292410 |
| 119 | Chronic diarrhea (HP:0002028) | 1.97785084 |
| 120 | Inflammation of the large intestine (HP:0002037) | 1.96986938 |
| 121 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96812622 |
| 122 | Seborrheic dermatitis (HP:0001051) | 1.96780526 |
| 123 | Hepatic necrosis (HP:0002605) | 1.94844320 |
| 124 | Abnormal platelet function (HP:0011869) | 1.94834531 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.94834531 |
| 126 | Testicular atrophy (HP:0000029) | 1.93711572 |
| 127 | Hemoptysis (HP:0002105) | 1.93680475 |
| 128 | Increased serum lactate (HP:0002151) | 1.93001363 |
| 129 | Cholelithiasis (HP:0001081) | 1.91901582 |
| 130 | Gingival bleeding (HP:0000225) | 1.91816326 |
| 131 | Colitis (HP:0002583) | 1.90994075 |
| 132 | Acute myeloid leukemia (HP:0004808) | 1.90865259 |
| 133 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90692120 |
| 134 | Obstructive lung disease (HP:0006536) | 1.90692120 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.90627388 |
| 136 | IgA deficiency (HP:0002720) | 1.90448363 |
| 137 | J-shaped sella turcica (HP:0002680) | 1.90350935 |
| 138 | Epistaxis (HP:0000421) | 1.88747465 |
| 139 | Chronic sinusitis (HP:0011109) | 1.87690497 |
| 140 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86645644 |
| 141 | Gingivitis (HP:0000230) | 1.85486673 |
| 142 | Retinal atrophy (HP:0001105) | 1.84262876 |
| 143 | Hypertensive crisis (HP:0100735) | 1.84231207 |
| 144 | Dicarboxylic aciduria (HP:0003215) | 1.84043899 |
| 145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84043899 |
| 146 | Fasciculations (HP:0002380) | 1.83208988 |
| 147 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83053444 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.83053444 |
| 149 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.82985508 |
| 150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81992103 |
| 151 | Periodontitis (HP:0000704) | 1.81568609 |
| 152 | Fatigue (HP:0012378) | 1.81090167 |
| 153 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.81042863 |
| 154 | Trismus (HP:0000211) | 1.80893340 |
| 155 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80877026 |
| 156 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80215631 |
| 157 | Myelodysplasia (HP:0002863) | 1.80008404 |
| 158 | Keratoconjunctivitis (HP:0001096) | 1.79603837 |
| 159 | Micronodular cirrhosis (HP:0001413) | 1.79556866 |
| 160 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78616263 |
| 161 | Spastic paraparesis (HP:0002313) | 1.78542197 |
| 162 | Secondary amenorrhea (HP:0000869) | 1.78496746 |
| 163 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.78298936 |
| 164 | Optic nerve coloboma (HP:0000588) | 1.78216242 |
| 165 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78174606 |
| 166 | Increased CSF lactate (HP:0002490) | 1.77818240 |
| 167 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77677924 |
| 168 | Reticulocytopenia (HP:0001896) | 1.77672706 |
| 169 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76749374 |
| 170 | Death in infancy (HP:0001522) | 1.76104060 |
| 171 | Generalized aminoaciduria (HP:0002909) | 1.75239173 |
| 172 | Abnormality of reticulocytes (HP:0004312) | 1.74603585 |
| 173 | Hepatosplenomegaly (HP:0001433) | 1.74163182 |
| 174 | Elevated alkaline phosphatase (HP:0003155) | 1.72766549 |
| 175 | Multiple enchondromatosis (HP:0005701) | 1.72630035 |
| 176 | Basal ganglia calcification (HP:0002135) | 1.70946029 |
| 177 | Reticulocytosis (HP:0001923) | 1.70838759 |
| 178 | Neutropenia (HP:0001875) | 1.70575249 |
| 179 | Rhabdomyolysis (HP:0003201) | 1.69933960 |
| 180 | Muscle stiffness (HP:0003552) | 1.69014635 |
| 181 | Lactic acidosis (HP:0003128) | 1.68966826 |
| 182 | B lymphocytopenia (HP:0010976) | 1.68054154 |
| 183 | Prolonged partial thromboplastin time (HP:0003645) | 1.67774894 |
| 184 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.67689632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.59755005 |
| 2 | TYK2 | 3.23352116 |
| 3 | JAK3 | 2.95422749 |
| 4 | KIT | 2.89403302 |
| 5 | IKBKE | 2.85910045 |
| 6 | ACVR1B | 2.73498981 |
| 7 | TBK1 | 2.59287533 |
| 8 | PBK | 2.58565925 |
| 9 | SCYL2 | 2.51641653 |
| 10 | TXK | 2.44281324 |
| 11 | FGFR4 | 2.37627280 |
| 12 | FLT3 | 2.35453808 |
| 13 | BUB1 | 2.34014861 |
| 14 | VRK2 | 2.22091303 |
| 15 | EPHA2 | 2.06852317 |
| 16 | TAOK3 | 2.02387367 |
| 17 | SMG1 | 2.00893489 |
| 18 | STK10 | 1.98562594 |
| 19 | ARAF | 1.93511627 |
| 20 | ZAP70 | 1.90106722 |
| 21 | STK16 | 1.80545146 |
| 22 | EEF2K | 1.79692589 |
| 23 | MAP3K3 | 1.78342707 |
| 24 | IRAK4 | 1.68982422 |
| 25 | NEK2 | 1.65743647 |
| 26 | RPS6KA4 | 1.65276781 |
| 27 | CDK12 | 1.62582963 |
| 28 | ERN1 | 1.57515711 |
| 29 | CDK8 | 1.52711373 |
| 30 | BTK | 1.50661022 |
| 31 | NLK | 1.45979162 |
| 32 | MAP3K13 | 1.45062125 |
| 33 | IKBKB | 1.43150162 |
| 34 | CSF1R | 1.41746192 |
| 35 | SRPK1 | 1.39839666 |
| 36 | TGFBR1 | 1.37040679 |
| 37 | CHUK | 1.36097947 |
| 38 | MAP3K14 | 1.34240984 |
| 39 | KDR | 1.32623299 |
| 40 | JAK1 | 1.31952927 |
| 41 | MAP3K6 | 1.30094567 |
| 42 | PRPF4B | 1.29081697 |
| 43 | ERBB4 | 1.27135290 |
| 44 | CDK19 | 1.25866791 |
| 45 | MOS | 1.25578654 |
| 46 | FGFR3 | 1.19003072 |
| 47 | NME2 | 1.18821468 |
| 48 | TESK2 | 1.13135069 |
| 49 | CDC7 | 1.12888648 |
| 50 | NEK1 | 1.11802821 |
| 51 | PIM1 | 1.11377267 |
| 52 | TAOK2 | 1.10890247 |
| 53 | BMPR2 | 1.10449357 |
| 54 | EIF2AK1 | 1.09487279 |
| 55 | MAPK11 | 1.06371510 |
| 56 | SYK | 1.05308331 |
| 57 | MAP3K8 | 1.04218033 |
| 58 | NME1 | 1.03571368 |
| 59 | LCK | 1.01554872 |
| 60 | MAPKAPK3 | 1.01475028 |
| 61 | ABL2 | 1.01109529 |
| 62 | TEC | 0.99892484 |
| 63 | KSR2 | 0.99884211 |
| 64 | PLK4 | 0.97340909 |
| 65 | NEK6 | 0.96020864 |
| 66 | DYRK3 | 0.93990697 |
| 67 | PKN2 | 0.92152131 |
| 68 | CDK4 | 0.91806582 |
| 69 | PASK | 0.91638545 |
| 70 | AURKA | 0.91109851 |
| 71 | MATK | 0.89843560 |
| 72 | EPHA3 | 0.88880094 |
| 73 | ITK | 0.88725868 |
| 74 | MELK | 0.88504867 |
| 75 | SIK3 | 0.86858308 |
| 76 | JAK2 | 0.86163321 |
| 77 | PDK2 | 0.85855341 |
| 78 | STK4 | 0.84244850 |
| 79 | MAP3K10 | 0.83858051 |
| 80 | LMTK2 | 0.83654355 |
| 81 | LRRK2 | 0.83560354 |
| 82 | BRSK1 | 0.82002728 |
| 83 | CLK1 | 0.81509443 |
| 84 | SIK1 | 0.80762363 |
| 85 | STK38L | 0.80615403 |
| 86 | GRK6 | 0.75788170 |
| 87 | PIK3CA | 0.74605391 |
| 88 | BLK | 0.73672004 |
| 89 | BCKDK | 0.73382333 |
| 90 | TLK1 | 0.72905886 |
| 91 | TTK | 0.71756810 |
| 92 | MAP2K3 | 0.71709152 |
| 93 | PLK1 | 0.70221951 |
| 94 | STK24 | 0.70191190 |
| 95 | WEE1 | 0.69778158 |
| 96 | MAP3K1 | 0.68465116 |
| 97 | MST1R | 0.66549160 |
| 98 | HCK | 0.65776388 |
| 99 | ATR | 0.64458180 |
| 100 | EIF2AK2 | 0.64370113 |
| 101 | AURKB | 0.61917718 |
| 102 | MAP3K12 | 0.61243597 |
| 103 | LYN | 0.60419328 |
| 104 | STK3 | 0.60246010 |
| 105 | TRIM28 | 0.60214820 |
| 106 | LATS1 | 0.59712443 |
| 107 | RAF1 | 0.59449647 |
| 108 | EPHB1 | 0.57104486 |
| 109 | TSSK6 | 0.56801196 |
| 110 | DYRK2 | 0.56469457 |
| 111 | MST4 | 0.55820741 |
| 112 | NEK9 | 0.55659335 |
| 113 | MAP3K5 | 0.54291834 |
| 114 | RPS6KB2 | 0.53245872 |
| 115 | TRIB3 | 0.53092987 |
| 116 | IRAK3 | 0.52758987 |
| 117 | TAOK1 | 0.52053872 |
| 118 | RIPK1 | 0.51006016 |
| 119 | CDK7 | 0.50824827 |
| 120 | BMX | 0.49896102 |
| 121 | PRKCI | 0.49050339 |
| 122 | MAP3K11 | 0.48735398 |
| 123 | VRK1 | 0.48584373 |
| 124 | BRAF | 0.48557628 |
| 125 | CCNB1 | 0.48287662 |
| 126 | CHEK1 | 0.48234414 |
| 127 | PAK4 | 0.47609205 |
| 128 | PAK1 | 0.47515772 |
| 129 | CSK | 0.46906242 |
| 130 | CHEK2 | 0.46820826 |
| 131 | DAPK1 | 0.46235894 |
| 132 | EIF2AK3 | 0.46193641 |
| 133 | PIM2 | 0.44817452 |
| 134 | CDK9 | 0.44343590 |
| 135 | CSNK2A1 | 0.42819062 |
| 136 | PDPK1 | 0.42226422 |
| 137 | BRSK2 | 0.42132973 |
| 138 | TESK1 | 0.38368389 |
| 139 | RPS6KA5 | 0.37790329 |
| 140 | MAP3K9 | 0.37358934 |
| 141 | MET | 0.37135387 |
| 142 | TGFBR2 | 0.35842219 |
| 143 | MAPKAPK2 | 0.33697611 |
| 144 | MARK3 | 0.32324806 |
| 145 | CDK6 | 0.31755653 |
| 146 | MYLK | 0.31610299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77826225 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.58492408 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.28676778 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.24351044 |
| 5 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.09830264 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.04071798 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.03449533 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.01320937 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.99115029 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95598721 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 1.94909376 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.94529752 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92320115 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88664282 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77158654 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76447568 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.69531884 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.69224548 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.64724997 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.58325472 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.57253661 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56764216 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54862931 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49818033 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49416120 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.48894871 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.46570994 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45967013 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45384085 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.43201866 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.40597982 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39646608 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38500181 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.37100944 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34002709 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33164753 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32357112 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31559457 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28371670 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27200125 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27192303 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.25429006 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.23977820 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23883265 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.19329245 |
| 46 | Spliceosome_Homo sapiens_hsa03040 | 1.17631224 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17058263 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16793196 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.14707141 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.14636596 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 1.13053186 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12742201 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10448345 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09303462 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08970117 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07907789 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07758873 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07226208 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06782646 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05900070 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05345013 |
| 62 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05085938 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04888484 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04751091 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02449889 |
| 66 | Malaria_Homo sapiens_hsa05144 | 1.01448094 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97629252 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95872408 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94136860 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91690782 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91317281 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91094038 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89572482 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89264853 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88805593 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87203635 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.84003520 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.81622529 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80153393 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79473888 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.79166126 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78809111 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76440924 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75628939 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75623377 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75083699 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75055567 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.74662246 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72821420 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72528173 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71623919 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70563429 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70542235 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70450812 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70448605 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67132421 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66271761 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65925742 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65775380 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64755786 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64570561 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62654337 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61300287 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60850475 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60060921 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57937815 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57669443 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.57553245 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57167521 |
| 110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56414348 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55854757 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55686381 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54309293 |
| 114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52026929 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51972028 |
| 116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51365177 |
| 117 | Purine metabolism_Homo sapiens_hsa00230 | 0.50006436 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49920394 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49623752 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.47814019 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47468679 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45426688 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44473296 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44380729 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43433388 |
| 126 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42771827 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40868028 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40030848 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35478173 |
| 130 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33550958 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.32603258 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31726695 |

